CATX
Price
$3.19
Change
+$0.13 (+4.25%)
Updated
Dec 31 closing price
84 days until earnings call
ESLOY
Price
$120.67
Change
-$0.64 (-0.53%)
Updated
Dec 31 closing price
64 days until earnings call
Ad is loading...

CATX vs ESLOY

Header iconCATX vs ESLOY Comparison
Open Charts CATX vs ESLOYBanner chart's image
Perspective Therapeutics
Price$3.19
Change+$0.13 (+4.25%)
Volume$1.01M
CapitalizationN/A
EssilorLuxottica
Price$120.67
Change-$0.64 (-0.53%)
Volume$30.53K
CapitalizationN/A
CATX vs ESLOY Comparison Chart
Loading...
CATX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ESLOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CATX vs. ESLOY commentary
Jan 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CATX is a Hold and ESLOY is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 02, 2025
Stock price -- (CATX: $3.19 vs. ESLOY: $120.67)
Brand notoriety: CATX and ESLOY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CATX: 56% vs. ESLOY: 81%
Market capitalization -- CATX: $751.25M vs. ESLOY: $90.98B
CATX [@Medical Specialties] is valued at $751.25M. ESLOY’s [@Medical Specialties] market capitalization is $90.98B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CATX’s FA Score shows that 0 FA rating(s) are green whileESLOY’s FA Score has 2 green FA rating(s).

  • CATX’s FA Score: 0 green, 5 red.
  • ESLOY’s FA Score: 2 green, 3 red.
According to our system of comparison, ESLOY is a better buy in the long-term than CATX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CATX’s TA Score shows that 5 TA indicator(s) are bullish while ESLOY’s TA Score has 3 bullish TA indicator(s).

  • CATX’s TA Score: 5 bullish, 3 bearish.
  • ESLOY’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CATX is a better buy in the short-term than ESLOY.

Price Growth

CATX (@Medical Specialties) experienced а -1.85% price change this week, while ESLOY (@Medical Specialties) price change was -0.76% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.63%. For the same industry, the average monthly price growth was -1.35%, and the average quarterly price growth was +2.78%.

Reported Earning Dates

CATX is expected to report earnings on Mar 27, 2025.

ESLOY is expected to report earnings on Mar 07, 2025.

Industries' Descriptions

@Medical Specialties (-0.63% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ESLOY($91B) has a higher market cap than CATX($751M). CATX (0.000) and ESLOY (0.000) have similar YTD gains . ESLOY has higher annual earnings (EBITDA): 6.23B vs. CATX (-39.08M). ESLOY has more cash in the bank: 1.69B vs. CATX (9.24M). CATX has less debt than ESLOY: CATX (2.55M) vs ESLOY (11.7B). ESLOY has higher revenues than CATX: ESLOY (25.4B) vs CATX (0).
CATXESLOYCATX / ESLOY
Capitalization751M91B1%
EBITDA-39.08M6.23B-1%
Gain YTD0.0000.000-
P/E RatioN/A34.13-
Revenue025.4B-
Total Cash9.24M1.69B1%
Total Debt2.55M11.7B0%
FUNDAMENTALS RATINGS
CATX vs ESLOY: Fundamental Ratings
CATX
ESLOY
OUTLOOK RATING
1..100
2250
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
12
Undervalued
PROFIT vs RISK RATING
1..100
10025
SMR RATING
1..100
9695
PRICE GROWTH RATING
1..100
9647
P/E GROWTH RATING
1..100
10040
SEASONALITY SCORE
1..100
95n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ESLOY's Valuation (12) in the null industry is in the same range as CATX (36) in the Biotechnology industry. This means that ESLOY’s stock grew similarly to CATX’s over the last 12 months.

ESLOY's Profit vs Risk Rating (25) in the null industry is significantly better than the same rating for CATX (100) in the Biotechnology industry. This means that ESLOY’s stock grew significantly faster than CATX’s over the last 12 months.

ESLOY's SMR Rating (95) in the null industry is in the same range as CATX (96) in the Biotechnology industry. This means that ESLOY’s stock grew similarly to CATX’s over the last 12 months.

ESLOY's Price Growth Rating (47) in the null industry is somewhat better than the same rating for CATX (96) in the Biotechnology industry. This means that ESLOY’s stock grew somewhat faster than CATX’s over the last 12 months.

ESLOY's P/E Growth Rating (40) in the null industry is somewhat better than the same rating for CATX (100) in the Biotechnology industry. This means that ESLOY’s stock grew somewhat faster than CATX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CATXESLOY
RSI
ODDS (%)
Bullish Trend 3 days ago
89%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
52%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
56%
MACD
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
54%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
53%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
50%
Advances
ODDS (%)
Bullish Trend 8 days ago
79%
Bullish Trend 10 days ago
56%
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 3 days ago
54%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
56%
Aroon
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
51%
View a ticker or compare two or three
Ad is loading...
CATX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ESLOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HISGX10.67N/A
N/A
Harbor Small Cap Growth Inv
DEVDX12.57N/A
N/A
Driehaus Event Driven
UBVTX80.09N/A
N/A
Undiscovered Managers Behavioral Val R3
CHDVX12.84N/A
N/A
Cullen High Dividend Equity I
MLMAX20.73N/A
N/A
Morgan Stanley Instl Global Core A

CATX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CATX has been closely correlated with STRR. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if CATX jumps, then STRR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CATX
1D Price
Change %
CATX100%
N/A
STRR - CATX
88%
Closely correlated
N/A
ANPCF - CATX
26%
Poorly correlated
N/A
DHR - CATX
26%
Poorly correlated
N/A
TMO - CATX
25%
Poorly correlated
N/A
BLFS - CATX
24%
Poorly correlated
N/A
More

ESLOY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ESLOY has been loosely correlated with ESLOF. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ESLOY jumps, then ESLOF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESLOY
1D Price
Change %
ESLOY100%
N/A
ESLOF - ESLOY
58%
Loosely correlated
N/A
QGEN - ESLOY
43%
Loosely correlated
N/A
ALC - ESLOY
38%
Loosely correlated
N/A
SMMNY - ESLOY
38%
Loosely correlated
N/A
CRL - ESLOY
35%
Loosely correlated
N/A
More